debates in the United Kingdom about improving incentives in health care. The most interesting innovation to emerge under perestroika is a pilot project in Leningrad and at two other sites which could radically change the financing of hospitals. Hitherto, the budget has gone from the ministry to the hospitals and to the polyclinics by bureaucratic procedure, a scene familiar in Britain. In future, however, the polyclinics (several under the territorial aegis of one hospital) will hold the budget. The hospital will be paid by the polyclinic for treatment carried out, and this payment apparently includes all costs from patient care to ancillary services and supplies. The polyclinic will receive something resembling a capitation fee and will pay the hospital at a fixed rate per operation.
In bailed out. A degree of central control will be maintained as the finance department of the ministry will estimate the relevant price, implying that price will not be the criterion of competition by hospitals to gain referrals (and money) from polyclinics. Hospitals which dispute the department of health prices-for example, claiming that they need more reimbursement for a particular procedure-can take up the matter with the department.
The USSR is ahead of Britain
In order to reduce patients' length of stay and referrals and emphasise prevention general practitioner budgets have been advocated in the United Kingdom. The irony is that the USSR is ahead of us in instituting a pilot project. The problems as well as the opportunities-including the cash limiting of primary care-are also being confronted in the Soviet Union. But how much actual competition will result? Is it reasonable to expect, for example, that polyclinics will change their patterns of referral to hospital? Officially, it is pointed out that this can be done only in coordination with the patient. But a polyclinic is based in a hospital and it might be naive to expect it to strike out on its own and refer elsewhere.
While basic pay will continue to be set centrally, as will basic manpower plans, greater pay flexibility may be seen in a devolution of certain decisions about extra increments to the pay of hospitals' chief doctors. As in the United Kingdom, trade unions and other interested organisations are consulted about changes in manpower and conditions. The general rule is that individuals cannot be sacked but must, after considerable negotiation, be transferred to another job in the health care system. Under Gorbachev perestroika is motivated by a desire to reduce mechanistic bureaucracy and to stimulate greater initiative and enterprise, to be achieved partly by the decentralisation of decision making and budget holding in industry, including the health care system. There will be gainers and losers. In the short term static wages and rising prices as elements of the market are introduced, coupled with some people gaining financially, may cause dissatisfaction at the same time as liberating people's talents. This is likely to occur in health care as well as in the economy as a whole. The prospects for perestroika in health care are therefore bound up with wider social, economic, and political issues, and the developing constellation of contrasting forces will be fascinating to observe. (Accepted 8 February 1989) ANY QUESTIONS What should be the management ofa symptomless woman whose routine cervical smear shows the presence of actinomyces-like organisms; she is using an intrauterine contraceptive device?
This subject was well reviewed by McEwan in 1986.' He points out that cervical cytology is an inaccurate-method for diagnosing the presence of this organism, leading to both false negative and false positive results. Nevertheless, "it is doubtful whether common sense allows this to be ignored whatever the scientific background"-in view of the fact that frank actinomycosis is characterised by an insidious onset and leads to severe illness with multiple pelvic abscesses. The latter condition is, however, rare, with only 200 cases of this disease reported before 1967 and only 30 between 1967 and 1980-although all of the latter were related to the intrauterine device.
McEwan quotes our study at the Margaret Pyke Centre, which showed that removal of the device, whether or not a new copper device was inserted, led to the disappearance of actinomyces-like organisms during monitoring by subsequent cervical smears at six to 12 months.2 Our subsequent experience has confirmed the disappearance of the organisms in almost every case, though not invariably, as first reported.
The follow up of all women with intrauterine devices is essential, and this point should be made clear before insertion. Symptoms often considered minor, such as episodes of pelvic pain, dyspareunia, irregular bleeding, and undiagnosed discharge, need to be considered seriously as possible indicators of pelvic infection of an insidious kind. If actinomyces is also shown on cervical cytology the threshold for removing the device (and culture) should be low. If there are positive results in a symptomatic patient specialist advice should be taken and prolonged courses of amoxycillin or tetracycline in high dosage are required.
When there are no symptoms it would be appropriate merely to exchange the device for a new copper one. The woman needs careful follow up with a smear at six months and specific instructions to return earlier should relevant symptoms occur. If repeat smears at six and 12 months are negative it is our policy to return to the routine cytology frequency for healthy women. -JOHN GUILLEBAUD, gynaecologist, London
